Anamnesis
Wáng**, female, age 41. Pathology report from Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine (上海交通大学医学院附属瑞金医院) dated 2023-10-11: (right breast) invasive ductal carcinoma, grade II, maximum diameter 1.0 cm. Immunohistochemistry: ER (95%+, strong staining), PR (95%+, strong staining), HER2 (1+), Ki67 (~20%+ in hot spots); 21-gene RS index 25. In situ carcinoma cell immunophenotype essentially matches the invasive component. Discharge summary from the same hospital dated 2024-01-22: post-radiotherapy of malignant tumor (after lumpectomy for right breast cancer).
Treatment plan
Perinatal NK immune cells, 2U intravenously, once monthly, 3 consecutive administrations.
- Therapy
- NK perinatal
- Delivery route
- Intravenous (IV)
Outcome
Follow-up is ongoing. Final data will be published once the monitoring window closes.
Physician conclusion
No adverse reactions observed. NK cells can modulate the body's immune function and eliminate pathogenic factors, effectively alleviating associated symptoms and boosting immunity.
Related cases
- Cervical岳** · 53
Appetite and sleep are normal, immunity improved, energy increased, fatigue reduced, work capacity…
- Gastric黄** · 55
The patient currently tolerates food well and general condition is stable. Post-treatment follow-up…
- Sarcoma卢** · 68
After cell therapy, work capacity improved, sleep duration shortened but psycho-emotional state…
Discuss your case
Share your diagnosis and history — the academic board responds within 24 hours with a preliminary assessment and protocol outline.
Get a consultation